168 related articles for article (PubMed ID: 36680513)
21. A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis.
Kim SJ; Yoon DH; Jaccard A; Chng WJ; Lim ST; Hong H; Park Y; Chang KM; Maeda Y; Ishida F; Shin DY; Kim JS; Jeong SH; Yang DH; Jo JC; Lee GW; Choi CW; Lee WS; Chen TY; Kim K; Jung SH; Murayama T; Oki Y; Advani R; d'Amore F; Schmitz N; Suh C; Suzuki R; Kwong YL; Lin TY; Kim WS
Lancet Oncol; 2016 Mar; 17(3):389-400. PubMed ID: 26873565
[TBL] [Abstract][Full Text] [Related]
22. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type.
Cai Q; Luo X; Liang Y; Rao H; Fang X; Jiang W; Lin T; Lin T; Huang H
Br J Cancer; 2013 Feb; 108(2):380-6. PubMed ID: 23299534
[TBL] [Abstract][Full Text] [Related]
23. Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Li ZM; Xia Y; Huang JJ; Huang HQ; Xia ZJ; Lin TY; Li S; Cai XY; Wu-Xiao ZJ; Jiang WQ
PLoS One; 2013; 8(5):e64158. PubMed ID: 23724031
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.
Li YJ; Yi PY; Li JW; Liu XL; Tang T; Zhang PY; Jiang WQ
Chin J Cancer; 2017 Jul; 36(1):62. PubMed ID: 28756771
[TBL] [Abstract][Full Text] [Related]
25. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
[TBL] [Abstract][Full Text] [Related]
27. A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma.
Wang L; Xia ZJ; Lu Y; Wang QX; Niu SQ; Huang HQ; Zhang YJ
Leuk Lymphoma; 2015; 56(11):3038-44. PubMed ID: 25747971
[TBL] [Abstract][Full Text] [Related]
28. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.
Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J
Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of Ki-67 antigen expression in extranodal natural killer/T-cell lymphoma, nasal type.
Jiang L; Li P; Wang H; Liu J; Zhang X; Qiu H; Zhang B
Med Oncol; 2014 Oct; 31(10):218. PubMed ID: 25204411
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Tian XP; Zhang YC; Lin NJ; Wang L; Li ZH; Guo HG; Ma SY; An MJ; Yang J; Hong YH; Wang XH; Zhou H; Li YJ; Rao HL; Li M; Hu SX; Lin TY; Li ZM; Huang H; Liang Y; Xia ZJ; Lv Y; Liu YY; Duan ZH; Chen QY; Wang JN; Cai J; Xie Y; Ong CK; Liu F; Liu YY; Yan Z; Huang L; Tao R; Li WY; Huang HQ; Cai QQ
Cell Rep Med; 2023 Feb; 4(2):100859. PubMed ID: 36812892
[TBL] [Abstract][Full Text] [Related]
31. Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
Kim SJ; Choi JY; Hyun SH; Ki CS; Oh D; Ahn YC; Ko YH; Choi S; Jung SH; Khong PL; Tang T; Yan X; Lim ST; Kwong YL; Kim WS;
Lancet Haematol; 2015 Feb; 2(2):e66-74. PubMed ID: 26687611
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
33. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Wei YC; Liu WX; Qi F; Zhang CG; Zheng BM; Xie Y; Chen B; Zhang D; Liu WP; Fang H; Chai Y; Qi SN; Li YX; Wang WH; Song YQ; Zhu J; Dong M
Ann Hematol; 2024 Jan; 103(1):163-174. PubMed ID: 37817010
[TBL] [Abstract][Full Text] [Related]
34. Impact of the peripheral blood inflammatory indices and modified nomogram-revised risk index on survival of Extranodal Nasal-Type Natural Killer/T-Cell lymphoma.
Hou Q; Li H; Liang Y; Yao N; Cao X; Liu J; Sun B; Feng P; Zhang W; Cao J
Cancer Biomark; 2024; 39(1):27-36. PubMed ID: 37522199
[TBL] [Abstract][Full Text] [Related]
35. Body mass index as a prognostic factor in patients with extranodal natural killer/T-cell lymphoma, nasal type.
Liu J; Deng YT; Zhang L; Li N; Jiang M; Zou LQ; Jiang Y
Oncotarget; 2016 Nov; 7(47):78159-78167. PubMed ID: 27556299
[TBL] [Abstract][Full Text] [Related]
36. The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Jiang WQ; Huang JJ; Xia ZJ; Huang HQ; Li ZM
Am J Hematol; 2013 May; 88(5):394-9. PubMed ID: 23423859
[TBL] [Abstract][Full Text] [Related]
37. A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma.
He Y; Luo Z; Chen H; Ping L; Huang C; Gao Y; Huang H
J Inflamm Res; 2024; 17():2089-2102. PubMed ID: 38595337
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of prognostic nutritional index in predicting the efficacy in patients with B-cell lymphoma.
Xiao L; Xiao S; Fan Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Feb; 45(2):139-143. PubMed ID: 32386038
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on ¹⁸F-FDG PET/CT in patients with extranodal NK/T-cell lymphoma.
Kim CY; Hong CM; Kim DH; Son SH; Jeong SY; Lee SW; Lee J; Ahn BC
Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1321-9. PubMed ID: 23674211
[TBL] [Abstract][Full Text] [Related]
40. A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.
Wu W; Ren K; Chen X; Li N; Zhou H; Jiang M; Yu Y; Zou L
Cancer Med; 2023 Apr; 12(8):9439-9448. PubMed ID: 36866811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]